Medicare Enrolled
Dr. Alan Dosik, MD
Internal Medicine · Brooklyn, NY
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Dosik from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Dosik?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Dosik
Dr. Alan Dosik is an internal medicine specialist in Brooklyn, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Dosik performed 51,629 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Dosik received a total of $9,371 from 77 pharmaceutical and/or device companies across 460 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Dosik is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 0% volume in NY
$9,371 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗51,629
Medicare services
Top 0% in NY for internal medicine
Not available
Unique patients (not deduplicated)
$8
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Injectafer) An intravenous injection of ferric carboxymaltose, an iron replacement medication. |
22,500 | $1 | $2 |
| Darbepoetin injection (Aranesp) for anemia An injection of darbepoetin alfa used for non-end-stage renal disease purposes. |
11,610 | $2 | $6 |
| Denosumab injection (Prolia/Xgeva) | 9,181 | $19 | $31 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
2,155 | $0 | $0 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
1,291 | $8 | $15 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
1,163 | $8 | $15 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
811 | $106 | $350 |
| Anti-nausea injection (Aloxi/palonosetron) | 695 | $1 | $14 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
387 | $10 | $50 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
284 | $82 | $250 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
259 | $13 | $50 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
211 | $27 | $80 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
211 | $125 | $300 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
106 | $19 | $50 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
103 | $58 | $150 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
98 | $1 | $5 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
92 | $32 | $100 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
83 | $27 | $250 |
| New patient office visit, complex (60-74 min) | 74 | $197 | $400 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
64 | $5 | $15 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
58 | $149 | $300 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
57 | $14 | $50 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
35 | $109 | $400 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
27 | $153 | $350 |
| Telephone medical discussion, 5-10 minutes A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters. |
26 | $45 | $100 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
23 | $36 | $74 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
13 | $72 | $135 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
12 | $119 | $475 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
44.8% high complexity
47.1% medium
8.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$9,371
Total received (2018-2024)
Avg $1,339/year across 7 years
Top 10% in NY for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
77
Companies
460
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,062
2023
$1,162
2022
$1,173
2021
$808
2020
$1,031
2019
$1,977
2018
$2,158
Payments by company (2024)
PFIZER INC.
$96
GlaxoSmithKline, LLC.
$80
ABBVIE INC.
$78
Roche Diagnostics Corporation
$74
Ipsen Biopharmaceuticals, Inc
$68
Merck Sharp & Dohme LLC
$65
Daiichi Sankyo Inc.
$60
Astellas Pharma US Inc
$55
Eisai Inc.
$50
Novartis Pharmaceuticals Corporation
$48
ARRAY BIOPHARMA INC
$40
Dendreon Pharmaceuticals LLC
$35
AstraZeneca Pharmaceuticals LP
$30
Incyte Corporation
$26
TAIHO ONCOLOGY, INC.
$24
E.R. Squibb & Sons, L.L.C.
$23
SOBI, INC
$22
SpringWorks Therapeutics, Inc.
$22
Coherus Biosciences Inc.
$22
Regeneron Healthcare Solutions, Inc.
$21
Kite Pharma, Inc.
$20
Janssen Biotech, Inc.
$19
Verity Pharmaceuticals Inc.
$19
Telix Pharmaceuticals
$19
JAZZ PHARMACEUTICALS INC.
$17
GENZYME CORPORATION
$17
Gilead Sciences, Inc.
$14
Top 3 companies account for 23.9% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$1,102
E.R. Squibb & Sons, L.L.C.
$740
AstraZeneca Pharmaceuticals LP
$538
PFIZER INC.
$463
Genentech USA, Inc.
$423
Incyte Corporation
$408
Merck Sharp & Dohme Corporation
$370
Daiichi Sankyo Inc.
$341
Pharmacyclics LLC, An AbbVie Company
$276
Gilead Sciences, Inc.
$239
Merck Sharp & Dohme LLC
$233
Dendreon Pharmaceuticals LLC
$232
Celgene Corporation
$226
Takeda Pharmaceuticals U.S.A., Inc.
$217
Exelixis Inc.
$191
Eisai Inc.
$182
Janssen Biotech, Inc.
$159
Astellas Pharma US Inc
$153
Lilly USA, LLC
$150
Seagen Inc.
$140
Amgen Inc.
$124
Boehringer Ingelheim Pharmaceuticals, Inc.
$121
Bayer HealthCare Pharmaceuticals Inc.
$114
Puma Biotechnology, Inc.
$113
Kite Pharma, Inc.
$109
GENZYME CORPORATION
$107
GE HealthCare
$104
Foundation Medicine, Inc.
$103
Coherus Biosciences Inc.
$100
GlaxoSmithKline, LLC.
$94
Ipsen Biopharmaceuticals, Inc
$93
EISAI INC.
$90
ABBVIE INC.
$78
Taiho Oncology, Inc.
$75
ARRAY BIOPHARMA INC
$74
Roche Diagnostics Corporation
$74
AMAG Pharmaceuticals, Inc.
$58
Karyopharm Therapeutics Inc.
$55
Myovant Sciences Inc.
$52
TAIHO ONCOLOGY, INC.
$45
Shire North American Group Inc
$43
Rigel Pharmaceuticals, Inc.
$42
Teva Pharmaceuticals USA, Inc.
$41
Regeneron Healthcare Solutions, Inc.
$41
PORTOLA PHARMACEUTICALS, INC.
$25
Sun Pharmaceutical Industries Inc.
$24
Eagle Pharmaceuticals, Inc.
$24
Mylan Institutional Inc.
$23
INSYS Therapeutics Inc
$22
SOBI, INC
$22
SpringWorks Therapeutics, Inc.
$22
Shield Therapeutics Inc
$22
Epizyme, Inc.,
$21
Deciphera Pharmaceuticals Inc.
$21
Array BioPharma Inc.
$21
EMD Serono, Inc.
$20
Dova Pharmaceuticals
$20
PUMA BIOTECHNOLOGY, INC.
$20
AbbVie, Inc.
$20
Amneal Pharmaceuticals LLC
$19
Agios Pharmaceuticals, Inc.
$19
Verity Pharmaceuticals Inc.
$19
Clovis Oncology, Inc.
$19
Telix Pharmaceuticals
$19
Global Blood Therapeutics, Inc.
$19
Seattle Genetics, Inc.
$18
Mirati Therapeutics, Inc.
$18
Stemline Therapeutics Inc.
$18
ADC Therapeutics America, Inc.
$18
JAZZ PHARMACEUTICALS INC.
$17
Sirtex Medical Inc
$17
Octapharma USA, Inc.
$17
G1 Therapeutics, Inc.
$17
Verastem, Inc.
$16
Pharmacyclics LLC, an AbbVie Company
$16
TerSera Therapeutics LLC
$15
ImmunoGen, Inc.
$13
Top 3 companies account for 25.4% of all-time payments
Associated products mentioned in payments ›
ABECMA · ACCRUFER · ADCETRIS · ADYNOVATE · AFINITOR · ALIMTA · ALYMSYS · ANDEXXA · Alecensa · Avastin · BENDEKA · BLENREP · BRAFTOVI · Bavencio · Braftovi · CABOMETYX · CALQUENCE · COSELA · CYRAMZA · Cabometyx · Copiktra · DARZALEX · DOPTELET · Doptelet · ELIQUIS · ELITEK · ENHERTU · EPKINLY · Elahere · Enhertu · Erleada · FASLODEX · FERAHEME · FOUNDATIONONE · FOUNDATIONONE CDX · FULPHILA · GAZYVA · IBRANCE · ILLUCCIX · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INREBIC · Imbruvica · Inrebic · JAKAFI · JARDIANCE · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · LENVIMA · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · Lupron · MEKINIST · MONJUVI · NERLYNX · NINLARO · Nerlynx · Nexavar · Nplate · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OGSIVEO · OJJAARA · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · Onivyde · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PROMACTA · PROVENGE · PYRUKYND · Perjeta · Pomalyst · Prolia · QINLOCK · REBLOZYL · RETACRIT · RYDAPT · Revlimid · Rubraca · Ryanodex Single Use Only - 250ml · SANDOSTATIN · SCEMBLIX · SIR-Spheres Microspheres · SPRYCEL · SUTENT · SYNDROS · Somatuline Depot · Stivarga · TAGRISSO · TALVEY · TASIGNA · TAZVERIK · TECENTRIQ · TUKYSA · Tavalisse · Trelstar · Trodelvy · Udenyca · VELCADE · VENCLEXTA · VERZENIO · VOTRIENT · VPRIV · XALKORI · XGEVA · XPOVIO · XTANDI · Xermelo · Xofigo · Xtandi · YONSA · Yescarta · ZEPZELCA
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Internal medicine physicians in nearby ZIP areas
10,770
County median income
$78,548
Nearest hospital to ZIP centroid (approximate)
MAIMONIDES MEDICAL CENTER
2.1 mi
2.1 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Dosik is a mixed practice specialist, with above-average Medicare volume (top 0% in NY), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Dosik experienced with iron infusion (injectafer)?
Based on Medicare claims data, Dr. Dosik performed 22,500 iron infusion (injectafer) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Dosik receive payments from pharmaceutical companies?
Yes. Dr. Dosik received a total of $9,371 from 77 companies across 460 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Dosik's costs compare to other internal medicine physicians in Brooklyn?
Dr. Dosik's average Medicare payment per service is $8. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Dosik) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Brooklyn
Browse internal medicine physicians in Brooklyn ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in NY
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in NY
Which NY internal medicine physicians receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology